BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37291702)

  • 1. Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants.
    Kim MH; Yuan SL; Lee KM; Jin X; Song ZY; Park JS; Cho YR; Lim K; Yun SC; Lee MS; Choi SY
    Eur Heart J Cardiovasc Pharmacother; 2023 Jul; 9(5):421-426. PubMed ID: 37291702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study.
    Besford M; Graham S; Sammon C; Mehmud F; Allan V; Alikhan R; Ramagopalan S
    Age Ageing; 2020 Jul; 49(4):679-682. PubMed ID: 32242616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
    Deguchi I; Osada T; Arai N; Takahashi S
    Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.
    Wang JR; Du X; Dong JZ; Chang SS; Jiang C; Sang CH; Long DY; Tang RB; Zhang HB; Guo JC; Wen YM; He L; Ma CS
    Clin Cardiol; 2022 Jan; 45(1):60-67. PubMed ID: 34952974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Friberg L; Andersson T; Rosenqvist M
    Eur Heart J; 2019 Jul; 40(28):2327-2335. PubMed ID: 31095295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation.
    Kim D; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Europace; 2021 Feb; 23(2):184-195. PubMed ID: 33063123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
    Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
    Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
    J Am Heart Assoc; 2022 Apr; 11(7):e023098. PubMed ID: 35301852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
    Rahman AA; Michaud J; Dell'Aniello S; Moodie EEM; Brophy JM; Durand M; Guertin JR; Boivin JF; Renoux C
    Neurology; 2023 Mar; 100(12):e1309-e1320. PubMed ID: 36581462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
    Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care.
    Mongkhon P; Alwafi H; Fanning L; Lau WCY; Wei L; Kongkaew C; Wong ICK
    Br J Clin Pharmacol; 2021 Mar; 87(3):1056-1068. PubMed ID: 32643166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study.
    Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Yun SC; Lip GYH
    Thromb Haemost; 2021 Sep; 121(9):1151-1160. PubMed ID: 33307565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice.
    Coleman CI; Peacock WF; Antz M
    Heart Lung Circ; 2018 Mar; 27(3):390-393. PubMed ID: 28528780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription status of oral anticoagulants in patients with acute cerebral infarction with non-valvular atrial fibrillation at the time of stroke onset.
    Deguchi I; Osada T; Takao M
    J Cardiol; 2020 May; 75(5):544-548. PubMed ID: 31843290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.